4.7 Article

Comparison of 24-Month Outcomes After Treatment for Distal Radius Fracture The WRIST Randomized Clinical Trial

期刊

JAMA NETWORK OPEN
卷 4, 期 6, 页码 -

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamanetworkopen.2021.12710

关键词

-

资金

  1. National Institute of Arthritis and Musculoskeletal and Skin Diseases
  2. National Institute on Aging of the National Institutes of Health [R01 AR062066, 2 K24-AR053120-06]

向作者/读者索取更多资源

This study compared outcomes across treatment groups at 24 months among older adults with DRFs. No clinically meaningful differences were found between groups at 24 months, with little change from 12 to 24 months. The rate of malunion was higher in the casting group, but malunion did not impact the 24-month outcome difference across groups.
IMPORTANCE Distal radius fractures (DRFs) are common injuries among older adults and can result in substantial disability. Current evidence regarding long-term outcomes in older adults is scarce. OBJECTIVE To compare outcomes across treatment groups at 24 months among adults with DRFs who participated in the WRIST trial. DESIGN, SETTING, AND PARTICIPANTS The Wrist and Radius Injury Surgical Trial (WRIST) randomized, international, multicenter trial was conducted from April 1, 2012, through December 31, 2016. Participants were adults aged 60 years or older with isolated, unstable DRFs at 24 health systems in the US, Canada, and Singapore. Data analysis was performed from March 2019 to March 2021. INTERVENTIONS Participants were randomized to open reduction and volar locking plate system (VLPS), external fixation with or without supplementary pinning (EFP), and percutaneous pinning (CRPP). The remaining participants chose closed reduction and casting. MAIN OUTCOMES AND MEASURES The primary outcome was the 24-month Michigan Hand Outcomes Questionnaire (MHQ) summary score. Secondary outcomes were scores on the MHQ subdomains hand strength and wrist motion. RESULTS A total of 304 adults were recruited for the study, and 187 were randomized to undergo surgery, 65 to VLPS, 64 to EFP, and 58 to CRPP; 117 participants opted for closed reduction and casting. Assessments were completed at 24 months for 182 participants (160 women [87.9%]; mean [SD] age, 70.1 [8.5] years). Mean MHQ summary scores at 24 months were 88 (95% CI, 83-92) for VLPS, 83 (95% CI, 78-88) for EFP, 85 (95% CI, 79-90) for CRPP, and 85 (95% CI, 79-90) for casting, with no clinically meaningful difference across groups after adjusting for covariates (chi(2)(3) = 1.44; P = .70). Pain scores also did not differ across groups at 24 months (chi(2)(3) = 2.64; P = .45). MHQ summary scores changed from 82 (95% CI, 80-85) to 85 (95% CI, 83-88) (P = .12) between 12 and 24 months across groups. The rate of malunion was higher in the casting group (26 participants [59.1%]) than in the other groups (4 participants [8.0%] for VLPS, 8 participants [17.0%] for EFP, and 4 participants [9.8%] for CRPP; chi(2)(3) = 43.6; P < .001), but malunion was not associated with the 24-month outcome difference across groups. CONCLUSIONS AND RELEVANCE The study did not find clinically meaningful patient-reported outcome differences 24 months after injury across treatment groups, with little change between 12 and 24 months. These findings suggest that long-term outcomes need not necessarily be considered in deciding between treatment options. Patient needs and recovery goals that fit to relative risks and benefits of each treatment type will be more valuable in treatment decision-making.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据